Company required independent advice on a pending publication that could potentially harm a blockbuster cardiovascular product. Personally selected as part of Issue Management Team to provide independent expertise. Met with Chair & established own academic credibility; contacted experts proposed by independent chair to secure their participation; assisted in prep & distribution of agenda & supporting documents; ensured experts were appropriately informed; and assisted at meeting. Succeeded in driving resolution of issues, protecting a $multi-million R&D investment.
An impartial view on the data interpretation was obtained from a highly respected advisory board of experts chosen by an independent chair. In these circumstances a company needs to know the truth – it’s the right thing to do.